Author Question: Which of the following statements about rules of debate on legislation is true? I. In the House, any ... (Read 125 times)

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Which of the following statements about rules of debate on legislation is true? I. In the House, any member who wishes to speak about a particular issue is given a specific amount of time to talk by the Speaker. II. In the House, once debate is closed, final conversation can occur in a specific amount of time before the vote is called. III. In the Senate, a member may keep discussing a bill after debate is closed to keep it from coming up for a vote. IV. Three-fifths of the Senate must vote to decide to close debate for a legislative matter.
 
  a. Statements I, II, and III
   b. Statements II and III
  c. Statements I and II
  d. Statements I, III, and IV

Question 2

Which of the following is false about the Rules Committee?
 
  a. There is a Rules Committee in the Senate.
  b. There is a Rules Committee in the House of Representatives.
  c. The Rules Committee decides whether and when a bill comes up for a full vote.
   d. The Rules Committee decides on the conditions for debate of the bill.



bassamabas

  • Sr. Member
  • ****
  • Posts: 294
Answer to Question 1

d

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library